1996
DOI: 10.1111/j.1476-5381.1996.tb15184.x
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular responses to intrathecal neuropeptide γ in conscious rats: receptor characterization and mechanism of action

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

1996
1996
2018
2018

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 55 publications
0
6
0
Order By: Relevance
“…Their maximal changes elicited by i.v. injections of increasing bolus (100 μ L) doses of EOOG (1–20 mg/kg) were determined in conscious rats which had been pretreated intravenously 10 min earlier with vehicle (1 mL/kg, n = 9) or propranolol (2 mg/kg, n = 6) [18–20]. When subsequent doses of EOOG were administered, MAP and HR were first allowed to return to their baseline levels, obtained before the first injection of the essential oil.…”
Section: Methodsmentioning
confidence: 99%
“…Their maximal changes elicited by i.v. injections of increasing bolus (100 μ L) doses of EOOG (1–20 mg/kg) were determined in conscious rats which had been pretreated intravenously 10 min earlier with vehicle (1 mL/kg, n = 9) or propranolol (2 mg/kg, n = 6) [18–20]. When subsequent doses of EOOG were administered, MAP and HR were first allowed to return to their baseline levels, obtained before the first injection of the essential oil.…”
Section: Methodsmentioning
confidence: 99%
“…Three minutes later, and 7 min before the second injection of EOCZ (10 mg/kg, i.a. ), the NK 1 ‐selective antagonist RP 67580 (7.8 nmol; at the L5–L6 level; 32 n = 7) or its vehicle ( n = 3) was administered i.t. and the maximal MAP and HR changes were again determined.…”
Section: Methodsmentioning
confidence: 99%
“…In contrast, the central actions of NPK were mediated solely by the NK1 receptor as no residual responses were observed when NPK was pretreated with RP 67,580 (6.5 nmol) in a protocol similar to the present study (Prat et al, 1994 (Unger et al, 1981;1985;Takano et al, 1990), while those induced by i.c.v. injection of NK3 agonists would result mainly from the release of vasopressin from the hypothalamus and to a minor extent by activation of the sympathetic nervous system (Polidori et al, 1989;Takano et al, 1990;1993 (Poulat et al, 1996). The hypothalamus may be the site of action of tachykinins since microinjections of SP into the anterior, ventromedial and medial preoptic parts of the hypothalamus of the awake unrestrained rat evoked cardiovascular and behavioural changes similar to those produced by i.c.v.…”
Section: Discussionmentioning
confidence: 99%
“…These effects on lung functions and human bronchus were inhibited by SR 48,968, suggesting that NPy exerts its effects via NK2 receptors (Qian et al, 1994;Yuan et al, 1994). On the other hand, when administered intrathecally (T-9 level) in the conscious rat, NPy (78 pmol-78 nmol) induced dose-dependent increases in heart rate and mean arterial blood pressure; these British Journal of Pharmacology (1996) 117,[241][242][243][244][245][246][247][248][249] effects were blocked by RP 67,580 (selective NKI receptor antagonist), but not by SR 48,968 or R 486 (selective NK3 antagonist) (Poulat et al, 1996).…”
Section: Introductionmentioning
confidence: 99%